Previous Guts UK Development Grant recipients

These are the previous recipients of Development Grants from Guts UK (formerly Core).

Title First and SurnameInstitutionTitle
Dr Michael BurkittUniversity of LiverpoolCharacterisation and assessment of the functional impact on gastric preneoplasia of the non-helicobacter gastric dysbiosis in Nfkb1-/- and Nfkb2-/- mice
Dr Laura Itzhaki University of CambridgeDeveloping chemical inhibitors of protein-protein interactions of oncoprotein gankyrin for the treatment of hepatocellular carcinoma and other cancers
Dr Naaventhan PalaniyappanUniversity of NottinghamQuantitative Magnetic Resonance Imaging (MRI) techniques in the evaluation and estimation of portal hypertension
Dr Tariq AhmedRoyal Devon & Exeter HospitalUK IBD Genetics Consortium Study of anti-TNF pharmacogenomics – predicting response and toxicity to anti-TNF drugs (= PANTS)
Dr Alexander Hal DrakesmithUniversity of OxfordUse of bone morphogenetic protein pathway agonists as antivirals against Hepatitis C virus
Dr Charlie LeesWestern General Hospital, EdinburghThe gut microbiota and NOD2 genotype in Crohn’s disease: a pilot study for the UKIBD Microbiota Consortium
Dr Tahera AnsariNorthwick Park Institute, HarrowThe development of a tissue engineered pouch
Dr Matthew BrookesNew Cross Hospital, WolverhamptonIs the tumour suppressor APC (ademonatous polyposis coli) crucial to iron mediated colorectal carcinogenesis?
Dr Sheena CruickshankUniversity of ManchesterMechanisms Underlaying the Development of Inflammatory Bowel Disease: The role of RANKL in dendritic cell activity
Professor Charles KnowlesQueen Mary UniversityA novel human in-vitro model of visceral pain using the appendix.
Dr Stuart McDonaldBarts and the LondonLocating the stem cell niche and tracing the origin and development and spread of epithelial cell lineages in the human colonic crypt
Professor David SandersRoyal Hallamshire HospitalCan a scoring system improve patient selection and outcome following PEG?
Dr Ann WilliamsUniversity of BristolFunctional analysis of BAG-1 in colorectal epithelial cells: BAG-1 as a regulator of NK-kappaB activity and disease progression of inflammatory bowel disease